Mirae Asset Global Investments Co., Ltd. Lyell Immunopharma, Inc. Transaction History
Mirae Asset Global Investments Co., Ltd.
- $20 Billion
- Q2 2024
A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Lyell Immunopharma, Inc. stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 7,611 shares of LYEL stock, worth $9,361. This represents 0.0% of its overall portfolio holdings.
Number of Shares
7,611Holding current value
$9,361% of portfolio
0.0%Shares
8 transactions
Others Institutions Holding LYEL
# of Institutions
123Shares Held
145MCall Options Held
2.6KPut Options Held
7.5K-
Mwg Management Ltd. Washington, DC20.2MShares$24.8 Million31.93% of portfolio
-
Apoletto LTD Washington, DC15.1MShares$18.6 Million42.56% of portfolio
-
Orland Properties LTD Washington, DC15.1MShares$18.6 Million16.63% of portfolio
-
Black Rock Inc. New York, NY13.5MShares$16.6 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.4MShares$16.5 Million0.0% of portfolio
About Lyell Immunopharma, Inc.
- Ticker LYEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 247,824,992
- Market Cap $305M
- Description
- Lyell Immunopharma, Inc., a T cell reprogramming company, engages in developing T cell therapies for patients with solid tumors. The company develops therapies using technology platforms, such as Gen-R, an ex vivo genetic reprogramming technology to overcome T cell exhaustion; and Epi-R, an ex vivo epigenetic reprogramming technology to generate...